Home/Filings/4/0001415889-24-014149
4//SEC Filing

Poirson Allen 4

Accession 0001415889-24-014149

CIK 0001831915other

Filed

May 21, 8:00 PM ET

Accepted

May 22, 6:41 PM ET

Size

20.6 KB

Accession

0001415889-24-014149

Insider Transaction Report

Form 4
Period: 2024-05-20
Poirson Allen
SVP Marketing and Corp. Dev.
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-20+79052,195 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-201,25228,804 total
    Common Stock (1,252 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-20+1,66953,556 total
  • Tax Payment

    Common Stock

    2024-05-20$5.96/sh308$1,83651,887 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-201,66928,374 total
    Common Stock (1,669 underlying)
  • Tax Payment

    Common Stock

    2024-05-20$5.96/sh651$3,88052,905 total
  • Tax Payment

    Common Stock

    2024-05-20$5.96/sh488$2,90853,669 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-207905,273 total
    Common Stock (790 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-20+1,25254,157 total
Footnotes (6)
  • [F1]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Includes 350 shares acquired by the Reporting Person under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2023.
  • [F3]Represents the number of shares withheld by and surrendered to the Issuer on May 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
  • [F4]The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.
  • [F5]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.
  • [F6]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2025 and each March 10 thereafter.

Issuer

Cytek Biosciences, Inc.

CIK 0001831915

Entity typeother

Related Parties

1
  • filerCIK 0001874301

Filing Metadata

Form type
4
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:41 PM ET
Size
20.6 KB